✦ LIBER ✦

T-cell gene therapy

✍ Scribed by Kristen M Hege; Margo R Roberts

Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 623 KB
Volume: 7
Category: Article
ISSN: 0958-1669
DOI: 10.1016/s0958-1669(96)80074-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stem cell biology and gene therapy

✍ Gary S. Stein 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 1 views

Tumor-cell-targeted cytokine gene therap

Tumor-cell-targeted cytokine gene therapy

✍ Mario P. Colombo; Giorgio Parmiani 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 390 KB

T-cell responses in photoimmune therapy

✍ Peter W. Heald; Hong Yong Kim; Maritza Perez; Richard L. Edelson; Carole L. Berg 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

The extracorporeal inactivation of a lymphocyte rich buffy coat suspension with ultraviolet A light and 8 methoxypsoralen can lead to dramatic clinical improvements following reinfusion of the damaged cells. This therapy is reviewed in the context of the disease it is most commonly used for: cutaneo

Prospects for adoptive T cell therapy

✍ Cassian Yee; Stanley R Riddell; Philip D Greenberg 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 796 KB

Since the establishment of methods to isolate genes encoding cytotoxic T lymphocyte defined tumor antigens, several antigens have been identified and characterized for suitability as target antigens for immunotherapy. The development of innovative strategies to generate T cells targeting these antig

Would suicide gene therapy solve the ‘T-

Would suicide gene therapy solve the ‘T-cell dilemma’ of allogeneic bone marrow transplantation?

✍ José L Cohen; Olivier Boyer; David Klatzmann 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Gene therapy of B-cell lymphoma with cyt

Gene therapy of B-cell lymphoma with cytokine gene-modified trioma cells

✍ John Strehl; Michael Selmayr; Jean-P. Kremer; Lothar Hültner; Horst Lindhofer; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 177 KB 👁 1 views

The trioma approach is a new immunotherapeutic strategy for treating B-cell lymphomas. It is based on converting the tumour idiotype to a bispecific immunoglobulin that redirects the idiotype to antigen-presenting cells. We show here that even pre-existing tumours can be eradicated by trioma vaccina